Global /United States /Healthcare /Medical Devices /KMTS
chevron_leftBack
Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd.

KMTS
NASDAQ: KMTS Delayed
19.51USD -9.9%
As of 16 June 2026, Kestra Medical Technologies, Ltd. has a market cap of $1.14B USD, ranking #9990 globally and #2074 in the United States. It ranks #878 in the Healthcare sector, and #180 in the Medical Devices industry.
Global Rank
9990
Country Rank
2074
Sector Rank
878
Industry Rank
180
Key Stats
Market Cap
$1.14BUSD
Enterprise Value
$947.79MUSD
Revenue (TTM)
$83.72MUSD
EBITDA (TTM)
-$135.39MUSD
Net Income (TTM)
-$148.12MUSD
EBITDA Margin
-162%
Profit Margin
-173%
PS Ratio
14.2
PB Ratio
4.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Brian Webster open_in_new
Employees
330
Founded
2014
IPO
06 Mar 2025
Website
kestramedical.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-9.9% -12% 5.1% -19% -27% -19%

News

Loading...

KMTS Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
KMTS
Kestra Medical Technologies Ltd
ISIN: BMG524411052
Shares Out.:
58.373M1 Shares Float: 19.283M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
19.51 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company’s develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
15K%
25.8
$160.73B
14K%
56.7
$159.07B
14K%
25.6
DHR
$126.55B
11K%
34.7
SYK
$120.69B
10K%
38.3
$84.93B
7K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
9K%
22.2
$97.77B
84.32B EUR
8K%
36.7
7741
$61.33B
9.83T JPY
5K%
40.0
$45.62B
39.34B EUR
4K%
18.7
ALC
$36.51B
28.99B CHF
3K%
37.9
$30.08B
203.66B CNY
3K%
26.0
chevron_leftBack